Literature DB >> 2757877

Severe pulmonary hypertension in Ullrich-Noonan syndrome.

A Tinker1, N Uren, J Schofield.   

Abstract

A 19 year old woman with Ullrich-Noonan syndrome presented with a six month history of progressive dyspnoea and cyanosis. Clinical features were suggestive of severe pulmonary hypertension. Cross sectional echocardiography showed pronounced right ventricular pressure overload with right ventricular hypertrophy. Cardiac catheterisation confirmed severe pulmonary hypertension. Attempts to reduce pulmonary artery pressure with calcium channel blockers were unsuccessful. The patient died shortly after investigation. Necropsy confirmed primary pulmonary hypertension.

Entities:  

Mesh:

Year:  1989        PMID: 2757877      PMCID: PMC1216735          DOI: 10.1136/hrt.62.1.74

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  12 in total

1.  The clinical diagnosis of atrial sefect defect in children.

Authors:  J R EVANS; R D ROWE; J D KEITH
Journal:  Am J Med       Date:  1961-03       Impact factor: 4.965

2.  The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects.

Authors:  D HEATH; J E EDWARDS
Journal:  Circulation       Date:  1958-10       Impact factor: 29.690

3.  The Ullrich-Noonan syndrome (Turner phenotype).

Authors:  J J Nora; A H Nora; A K Sinha; R D Spangler; H A Lubs
Journal:  Am J Dis Child       Date:  1974-01

4.  Natural history and prognosis of atrial septal defect.

Authors:  R J Craig; A Selzer
Journal:  Circulation       Date:  1968-05       Impact factor: 29.690

5.  Characteristic cardiovascular anomalies of XO Turner syndrome, XX and XY phenotype and XO-XX Turner mosaic.

Authors:  J J Nora; F G Torres; A K Sinha; D G McNamara
Journal:  Am J Cardiol       Date:  1970-06       Impact factor: 2.778

Review 6.  Primary pulmonary hypertension.

Authors:  S G Haworth
Journal:  Br Heart J       Date:  1983-06

Review 7.  Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards.

Authors:  M Packer
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

8.  Pulmonary vascular disease in secundum atrial septal defect in childhood.

Authors:  S G Haworth
Journal:  Am J Cardiol       Date:  1983-01-15       Impact factor: 2.778

9.  Primary pulmonary hypertension: natural history and the importance of thrombosis.

Authors:  V Fuster; P M Steele; W D Edwards; B J Gersh; M D McGoon; R L Frye
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

10.  High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

Authors:  S Rich; B H Brundage
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

View more
  7 in total

1.  Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension.

Authors:  Mei-Sing Ong; Mary P Mullen; Eric D Austin; Peter Szolovits; Marc D Natter; Alon Geva; Tianxi Cai; Sek Won Kong; Kenneth D Mandl
Journal:  Circ Res       Date:  2017-06-13       Impact factor: 17.367

Review 2.  The genetic basis of pulmonary arterial hypertension.

Authors:  Lijiang Ma; Wendy K Chung
Journal:  Hum Genet       Date:  2014-01-21       Impact factor: 4.132

3.  Early-lethal Costello syndrome due to rare HRAS Tandem Base substitution (c.35_36GC>AA; p.G12E)-associated pulmonary vascular disease.

Authors:  K Nicole Weaver; Dehua Wang; James Cnota; Nicholas Gardner; Deborah Stabley; Katia Sol-Church; Karen W Gripp; David P Witte; Kevin E Bove; Robert J Hopkin
Journal:  Pediatr Dev Pathol       Date:  2014-08-18

4.  Noonan syndrome with double-chambered right ventricle.

Authors:  S Ozkutlu; E Cil; I Paşaoğlu; M Saraçlar
Journal:  Pediatr Cardiol       Date:  1996 Jul-Aug       Impact factor: 1.655

Review 5.  Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management.

Authors:  Angela E Lin; Craig T Basson; Elizabeth Goldmuntz; Pilar L Magoulas; Deborah A McDermott; Donna M McDonald-McGinn; Elspeth McPherson; Colleen A Morris; Jacqueline Noonan; Catherine Nowak; Mary Ella Pierpont; Reed E Pyeritz; Alan F Rope; Elaine Zackai; Barbara R Pober
Journal:  Genet Med       Date:  2008-07       Impact factor: 8.822

Review 6.  Signaling networks in immunometabolism.

Authors:  Jordy Saravia; Jana L Raynor; Nicole M Chapman; Seon Ah Lim; Hongbo Chi
Journal:  Cell Res       Date:  2020-03-20       Impact factor: 25.617

Review 7.  Genetics and Genomics of Pediatric Pulmonary Arterial Hypertension.

Authors:  Carrie L Welch; Wendy K Chung
Journal:  Genes (Basel)       Date:  2020-10-16       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.